EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Bioequivalence study of two formulations of afatinib dimaleate tablets in healthy subjects under fasting conditions: A randomized, open-label, single-dose, crossover trial

Yanping Liu, Lang Lü, Man Xu, Juanmin Tao, Yuping Ning, Yan Shi, Yanfen Dong, Qingqing Cao, Jun Ma, Yan Qiu

Int. Journal of Clinical Pharmacology and Therapeutics · 2024

DOI: 10.5414/cp204514 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2024. Verfasst von Yanping Liu und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cross-Over Studies, Therapeutic Equivalency, Fasting, Tablets.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross-Over StudiesTherapeutic EquivalencyFastingTabletsHealthy VolunteersAfatinibHumansMaleAdultYoung AdultFemaleArea Under CurveAdministration, OralDrugs, GenericProtein Kinase Inhibitors

Substanzen

TabletsAfatinibDrugs, GenericProtein Kinase Inhibitors

Zitieren

APA

Liu, Y., Lü, L., Xu, M., Tao, J., Ning, Y., Shi, Y., Dong, Y., Cao, Q., Ma, J., & Qiu, Y. (2024). Bioequivalence study of two formulations of afatinib dimaleate tablets in healthy subjects under fasting conditions: A randomized, open-label, single-dose, crossover trial. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204514

Vancouver

Liu Y, Lü L, Xu M, Tao J, Ning Y, Shi Y, et al. Bioequivalence study of two formulations of afatinib dimaleate tablets in healthy subjects under fasting conditions: A randomized, open-label, single-dose, crossover trial. Int. Journal of Clinical Pharmacology and Therapeutics. 2024. doi:10.5414/cp204514

BibTeX
@article{Liu2024,
  author = {Liu, Yanping and Lü, Lang and Xu, Man and Tao, Juanmin and Ning, Yuping and Shi, Yan and Dong, Yanfen and Cao, Qingqing and Ma, Jun and Qiu, Yan},
  title = {Bioequivalence study of two formulations of afatinib dimaleate tablets in healthy subjects under fasting conditions: A randomized, open-label, single-dose, crossover trial},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.5414/cp204514}
}
Kostenlos starten →